why choose us

Clinical Trials Search

Showing 18,220 of 132,963 result(s)
Lung Ultrasound as a Predictor for Successful Extubation in Preterm Infants

Status: Completed

Condition: no Conditions

Interventions: Diagnostic Test: Lung Ultrasound (LUS)
LUS performed 30 mins prior to and 120 minutes after planned extubation with a linear high frequency probe

Date: 2022-11-16

Health Status of < 50 Year Old Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2020)

Status: Completed

Condition: Aortic Valve Disease

Interventions: Device: Aortic Valve Replacement
Surgical replacement of aortic valves

Date: 2022-11-16

Comparison Between Topical Mitomycin C and Cyclosporine

Status: Completed

Condition: Pterygium

Interventions: Interventional

Date: 2022-11-16

Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

Status: Completed

Condition: Safety
Bioavailability
Pharmacokinetics

Interventions: Interventional

Date: 2022-11-16

Expanded Access Program for Magrolimab

Status:

Condition:

Interventions: Biological: Magrolimab
Administered intravenously
Other Name: GS-4721

Date: 2022-11-16

AVL200 IOL for Treatment of Cataract and Presbyopia

Status: COMPLETED

Condition: Cataract

Interventions: The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.

Date: 2022-11-16

Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)

Status: COMPLETED

Condition: Chronic Hepatitis B Virus (Hbv)

Interventions:

Date: 2022-11-16

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Status: COMPLETED

Condition: Hearing Loss Ototoxic

Interventions: Patients will receive SENS-401 ((R)-azasetron besylate) B.I.D. up to 23 weeks: 1 week prior to the initiation of the cisplatin treatment, during the w

Date: 2022-11-16

Daytime Cyclic Enteral Nutrition Versus Standard Continuous Enteral Nutrition in the Intensive Care Unit: a Pilot Randomized Controlled Trial

Status: COMPLETED

Condition: Enteral Nutrition

Interventions: Continuous isocaloric enteral feeding (1kcal;ml) with 4g of protein per 100 mL for 10 hours during the day (e.g.
08:00 to 18:00), via nasal

Date: 2022-11-16

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Status: COMPLETED

Condition: Developmental and Epileptic Encephalopathy

Interventions: LP352 6 mg, 9 mg or 12 mg administered three times daily, orally or through G-tube

Date: 2022-11-15